Our primary focus is oncology, where we endeavor to address the full continuum of cancer from early to late disease stages. We approach the root causes of cancer treatment failure – cancer heterogeneity and interindividual variability – through innovative therapeutic modalities with the aim to expand treatment options for patients.
